BORIS, a novel cancer-testis antigen, is a potential target for immunotherapy in epithelial ovarian cancer
2005 ◽
Vol 23
(16_suppl)
◽
pp. 9673-9673
Keyword(s):
2007 ◽
Vol 13
(5)
◽
pp. 1421-1428
◽
Keyword(s):
2017 ◽
Vol 145
(3)
◽
pp. 413-419
◽
Keyword(s):
Keyword(s):
Keyword(s):
2006 ◽
Vol 54
(1)
◽
pp. S272.2-S272
Keyword(s):